Program for preventing risks in patients with uncontrolled epilepsy
Official title: Evaluate the Impact of a Specific Risk Prevention Program Associated With a Therapeutic Patient Education Program on the Risk Behaviors of Adult Patients With Uncontrolled Epilepsy.
Run by University Hospital, Montpellier · NCT06202196 · Data updated 2026-11-12
This study is testing a new program to help young adults with uncontrolled epilepsy learn better self-management skills by providing extra support and education.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 74 (estimated) |
| Sponsor | University Hospital, Montpellier Academic / other |
| Locations | 2 sites (Montpellier and 1 other locations) |
| Status | Recruiting |
| Started | April 16, 2024 |
| Main results expected | April 16, 2028 |
| Study ends | April 16, 2028 |
| Registry record updated | July 13, 2026 |
| Trial ID | NCT06202196 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 40 with poorly controlled epilepsy who are willing to participate in a therapeutic education program.
✕Probably not a fit
Patients with major cognitive impairments or those who have previously participated in a therapeutic education program may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study evaluates a risk prevention program integrated into therapeutic patient education for individuals aged 18 to 40 with uncontrolled epilepsy. Participants will be randomly assigned to either an intervention group, which receives additional risk management consultations, or a control group that receives standard care. The study aims to assess the impact of this program on patients' self-management skills related to epilepsy three months after the last educational session. The effectiveness will be measured using the Safety Management score from the Epilepsy Self Management Scale.
Why it matters
Potential benefit: If successful, this program could enhance self-management skills and reduce risks associated with uncontrolled epilepsy.
How similar studies have gone: While similar approaches have been explored, this specific integration of risk prevention into therapeutic education is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient between 18 and 60 years old * Patient with poorly controlled epilepsy (persistence of seizures evolving for more than a year despite proper treatment) or patient seizure-free for over a year but for whom therapeutic patient education (TPE) would be beneficial according to the investigator.. * Patient agreeing to participate in a therapeutic education program (TPE) Exclusion Criteria: * Epileptic patient who has already benefited from a TPE epilepsy program * Patients with major cognitive impairment * Patient under guardianship or legal protection (safeguard of justice) * Pregnant or breast-feeding women * Failure to obtain written informed consent after a reflection period * Patient who for geographical, social or psychological reasons could not participate in the research * Any situation that, in the opinion of the investigator, could present risks to the patient and to the research * Participation in another therapeutic research * Subjects not covered by public health insurance
Where it's running
-
CHU Gui de Chauliac
Montpellier, France Recruiting -
CHU de Toulouse
Toulouse, France Recruiting
Study contacts
- Study coordinator: Alice Catheland, Nurse
- Email: a-catheland@chu-montpellier.Fr
- Phone: +33 4.67.33.78.78
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
RAP-219 long-acting injectable safety and PK study in healthy adults
This early study tests RAP-219-LAI in healthy adults to see how it behaves in the body and whether it is safe and tolerable.
-
Why People with Epilepsy Get More Infections
This study tests whether anti-seizure medicines affect immune function and infection risk in people with epilepsy.
-
Long-Term Epilepsy Outcomes in Children After Perinatal Stroke
This study looks at how epilepsy progresses in kids who had a stroke before 28 days old to see how their seizures and syndromes evolve over time.
-
Hypothalamus structure and heart autonomic changes in drug-resistant epilepsy
This study tests whether structural changes in the hypothalamus relate to cardiac autonomic dysfunction in adults with drug-resistant epilepsy.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Advanced 7T fMRI for brain function in epilepsy and brain injuries
This study tests ultra-high-field brain scans at 7T to see if they can better map brain function in adults with epilepsy or brain lesions and in healthy volunteers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.